Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Predicted Market Size Trajectory For The Non-Hormonal Contraceptives Market From 2025 To 2034?
The non-hormonal contraceptives market size has witnessed substantial expansion in recent years. It is anticipated to grow from $23.73 billion in 2024 to $25.47 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.3%. The market’s past growth can be attributed to increasing support for women’s health initiatives, the expanding availability of over-the-counter non-hormonal contraceptive options, a heightened emphasis on male contraceptive product development, a surge in demand for fertility-awareness-based contraceptive solutions, and a rising number of product approvals and launches within the non-hormonal sector.
The market for non-hormonal contraceptives is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $33.48 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 7.1%. This projected expansion during the forecast period stems from factors such as a growing demand for hormone-free birth control options, heightened recognition of adverse effects linked to hormonal contraceptives, a burgeoning inclination towards natural and chemical-free contraception, an escalating incidence of sexually transmitted infections, and a greater emphasis on reproductive health among women. Key trends anticipated within this period encompass progress in biomaterials utilized for non-hormonal contraceptive devices, innovation propelled by technology in barrier contraceptive designs, the incorporation of intelligent tracking functionalities into fertility-awareness approaches, developments in drug-free contraceptive gels and films, and the emergence of technology-supported tools for self-administering contraceptive devices.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25849&type=smp
What Are The Emerging Market Drivers Creating New Opportunities In The Non-Hormonal Contraceptives Industry?
The anticipated expansion of the non-hormonal contraceptives market is linked to the increasing incidence of sexually transmitted diseases. Infections known as sexually transmitted diseases (STDs) primarily transmit through sexual contact and originate from bacteria, viruses, or parasites. A primary factor contributing to the rise in sexually transmitted diseases is reduced condom use, which heightens the risk of infection during sexual activity without protection. Non-hormonal contraceptive methods, such as male and female condoms, aid in preventing the spread of sexually transmitted diseases by forming a physical barrier that stops the transfer of bodily fluids during intercourse. An illustrative example is from April 2025, when data from the Minnesota Department of Health (MDH), a US-based state health agency, showed that the percentage of HIV cases among males aged 35 to 39 rose from 10% in 2023 to 17% in 2024. Consequently, the increasing occurrence of sexually transmitted diseases is a key factor propelling the expansion of the non-hormonal contraceptives market.
What Are The Major Segments Identified In The Non-Hormonal Contraceptives Market?
The non-hormonal contraceptives market covered in this report is segmented –
1) By Type: Devices, Sterilization, Other Product Types
2) By Mechanism Of Action: Antagonist, Agonist, Inhibitor, Modulator
3) By Route of Administration: Intramuscular, Intravaginal, Intravenous, Oral, Subcutaneous, Topical, Transdermal, Other Route Of Administrations
4) By Purpose Of Therapy: Treatment Of Disease, Management Of Symptoms
5) By Target Indication: Bacterial Vaginosis, Contraception, Endometriosis, Postmenopausal Osteoporosis, Uterine Fibroids, Vaginitis, Other Target Indications
Subsegments:
1) By Devices: Surgical Instruments, Ligation Clips, Tubal Rings
2) By Sterilization: Permanent Sterilization, Reversible Sterilization, Mechanical Sterilization Devices
3) By Other Product Types: Non-Surgical Barrier Devices, Implantable Plugs, Intrauterine Permanent Devices
Which Competitive Trends Are Defining The Non-Hormonal Contraceptives Market Structure?
Major companies operating in the non-hormonal contraceptives market are prioritizing the development of innovative solutions, such as preloaded intrauterine device delivery systems, to streamline insertion procedures, enhance user convenience, and improve clinical efficiency. A preloaded intrauterine device (IUD) delivery system is characterized as a pre-assembled, ready-to-use device that integrates the preloaded intrauterine device and its inserter into a single unit, intended to simplify the insertion process, reduce setup time, and minimize the risk of contamination or handling errors. For example, in September 2024, CooperSurgical Inc., a US-based medical device and fertility company, launched the Paragard Single-Handed Inserter, designed to boost insertion efficiency and patient comfort during non-hormonal preloaded intrauterine device placement. It offers over 99% effective, long-term birth control for up to 10 years by preventing sperm from fertilizing an egg. Its key advantages encompass immediate and reversible contraception, hormone-free suitability, and low maintenance once inserted.
Which Key Market Players Are Investing In Expansion And Innovation Of Non-Hormonal Contraceptives Market?
Major companies operating in the non-hormonal contraceptives market are Bayer AG., Church & Dwight Co., Mankind Pharma Limited, Okamoto Industries, CooperSurgical Inc., PSI India Pvt Ltd., Karex Berhad, Natural Cycles Nordic AB, Fuji Latex Co. Ltd., PREGNA INTERNATIONAL LTD., Cupid Limited, Veru Inc., Evofem Biosciences Inc., Daré Bioscience Inc., Global Protection Corp., SMB Corporation of India, HLL Lifecare Limited, YourChoice Therapeutics Inc., Cirqle Biomedical Contraception ApS, Eppin Pharma Inc., Contraline Inc., Linepharma International Ltd.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/non-hormonal-contraceptives-global-market-report
How Do Regional Market Performances Compare Within The Non-Hormonal Contraceptives Industry?
North America was the largest region in the non-hormonal contraceptives market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-hormonal contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Non-Hormonal Contraceptives Market Report:
https://www.thebusinessresearchcompany.com/customise?id=25849&type=smp
Browse Through More Reports Similar to the Global Non-Hormonal Contraceptives Market 2025, By The Business Research Company
Hormonal Contraceptives Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-global-market-report
Contraceptives Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/contraceptives-global-market-report
Oral Contraceptive Pills Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model